Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
618
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
+176K
-
Total reported value, excl. options
-
$10.3B
-
Value change
-
+$74.3M
-
Put/Call ratio
-
2.05
-
Number of buys
-
305
-
Number of sells
-
-267
-
Price
-
$411.85
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q2 2024
675 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q2 2024.
Medpace Holdings, Inc. - Common Stock (MEDP) has 618 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 28.4M outstanding shares and own 88.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.58M shares), VANGUARD GROUP INC (2.53M shares), WASATCH ADVISORS LP (967K shares), Invesco Ltd. (807K shares), STATE STREET CORP (703K shares), GOLDMAN SACHS GROUP INC (675K shares), GEODE CAPITAL MANAGEMENT, LLC (584K shares), RIVERBRIDGE PARTNERS LLC (536K shares), TD Asset Management Inc (511K shares), and BESSEMER GROUP INC (484K shares).
This table shows the top 618 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.